Assessment of type I interferon response in routine practice in France in 2022.

Autor:	Nombel A; Immunology Laboratory, Hôpital Lyon-Sud, Hospices Civils de Lyon, Lyon, France.; International Center of Infectiology Research (CIRI), INSERM U1111, CNRS, UMR5308, ENS of Lyon, Claude Bernard University Lyon 1, Lyon, France., Foray AP; Immunology Laboratory, Hôpital Lyon-Sud, Hospices Civils de Lyon, Lyon, France., Garnier L; Immunology Laboratory, Hôpital Lyon-Sud, Hospices Civils de Lyon, Lyon, France., Lombard C; Immunology Laboratory, Hôpital Lyon-Sud, Hospices Civils de Lyon, Lyon, France., Hachulla E; Département de Médecine Interne et d'Immunologie Clinique, Centre National de Référence Maladies Systémiques et Auto-immunes Rares Nord et Nord-Ouest de France (CeRAINO), European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNECT), Université de Lille, CHU Lille, Lille, France., Bader-Meunier B; Department of Paediatric Hematology-Immunology and Rheumatology, Reference center for Rheumatic, AutoImmune and Systemic diseases in children (RAISE), Necker-Enfants Malades Hospital, AP-HP, Paris, France., Georgin-Lavialle S; Service Médecine Interne, Centre de référence des maladies autoinflammatoires et des amyloses (CEREMAIA), Hôpital Tenon, AP-HP, Paris, France., Melki I; General Paediatrics, Department of Infectious Disease and Internal Medicine, Reference center for Rheumatic, AutoImmune and Systemic diseases in children (RAISE), Robert Debré Mother-Child University Hospital, AP-HP, Paris, France., Walzer T; International Center of Infectiology Research (CIRI), INSERM U1111, CNRS, UMR5308, ENS of Lyon, Claude Bernard University Lyon 1, Lyon, France., Belot A; International Center of Infectiology Research (CIRI), INSERM U1111, CNRS, UMR5308, ENS of Lyon, Claude Bernard University Lyon 1, Lyon, France sebastien.viel@inserm.fr alexandre.belot@chu-lyon.fr.; Pediatric Nephrology, Rheumatology, Dermatology Department, National Referee Centre for Rheumatic and Autoimmune Diseases in Children (RAISE), Hôpital Femme-Mère Enfant, Hospices Civils de Lyon, Lyon, France., Viel S; Immunology Laboratory, Hôpital Lyon-Sud, Hospices Civils de Lyon, Lyon, France sebastien.viel@inserm.fr alexandre.belot@chu-lyon.fr.; International Center of Infectiology Research (CIRI), INSERM U1111, CNRS, UMR5308, ENS of Lyon, Claude Bernard University Lyon 1, Lyon, France.
Jazyk:	angličtina
Zdroj:	RMD open [RMD Open] 2023 Jun; Vol. 9 (2).
DOI:	10.1136/rmdopen-2023-003211
Abstrakt:	An European Alliance of Associations for Rheumatology task force recently recommended specific points to consider for exploring type I interferon pathway in patients, highlighting the lack of analytical assays validated for clinical routine. We report here the French experience on a type I interferon pathway assay that has been set up and used routinely since 2018 in Lyon, France. Competing Interests: Competing interests: None declared. (© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu